Skip to main content
Premium Trial:

Request an Annual Quote

AlgoNomics, Genmab Collaborate on Antibody Research

NEW YORK (GenomeWeb News) – Belgium’s AlgoNomics has entered into a research partnership with the Danish antibody company Genmab, the company announced today.
 
AlgoNomics plans to assist Genmab with detailed structural analysis of its fully human antibody molecules and antibody scaffolds, including Genmab’s new small, stable, modified antibody technology, UniBody.
 
Combined with experimental data, the companies believe structural information gleaned from AlgoNomics’ antibody structure database and structure-based protein and peptide design platform, Tripole, may reveal new functional or therapeutic properties for Genmab’s products.
 
AlgoNomics said that it will be eligible for Genmab research funding and milestone payments under the agreement, but did not disclose any other financial details or additional information about potential therapeutics.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.